Cochlear Implants Market is Growing Steadily at a Promising CAGR of 9.86% During Forecast 2017-2023


Market Overview:
The global Cochlear Implants Market is anticipated to grow at a CAGR of 9.86% and is due to reach USD 3,203.8 Mn over the forecast period of 2017-2023, projects Market Research Future (MRFR) in a detailed report.

Cochlear implants are medical devices that are surgically inserted to provide a sense of sound to a person with hearing loss. The last few years have witnessed a significant increase in the demand for cochlear implants owing to the rise in a number of patients with hearing impairment who generate demand for diagnosis and treatment. The Centers for Disease Control and Prevention estimates that by 2025, 900 Mn people are likely to suffer from hearing impairment.

The rise in global geriatric population is also expected to be a positive factor influencing the growth of the global cochlear implants market. The aged populace is more susceptible to hearing loss which induces high demand for cochlear implants.


Competitive Landscape:
·         MED-El
·         Microson S.A.
·         Widex
·         GAES MÉDIC
·         Cochlear Ltd
·         William Demant Holding Group
·         Advanced Bionics AG

Segmentation:
·         The global cochlear implants market has been segmented based on product, type, and end user.

·         By product, the global cochlear implants market has been segmented into a cochlear implant system, and accessories & upgrades.

·         By types, the global cochlear implants market has been segmented into cochlear implant system, and accessories & upgrades.

·         By end user, the global cochlear implants market has been segmented into hospitals & clinics, ambulatory surgical centers, research & academic institutes, and others.
Regional Analysis:
The Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa are the key markets for cochlear implants. The Americas represent a significant market for cochlear implants owing to the presence of a vast patient population. Rising geriatric population, increasing demand for advanced treatment options and affordability are key factors determining the growth of the Americas market.

Europe accounts for the second largest share of the global cochlear market. The Europe market is driven by strong government support, availability of funds for R&D activities and high expenditure on healthcare.

Asia Pacific follows Europe closely and is slated to be the fastest growing market over the forecast period. Rapid advancement in medical technology in the region and the presence of considerable patient pool in the region drives the market for cochlear implants. Also, improving reimbursement scenario, the growing need for better medical devices, and expanding expenditure on healthcare due to a rise in disposable income has created a conducive environment for the growth of the market. China and India are the key contributors to the APAC market.

The MEA market accounts for the least share of the global cochlear implants market. Limited availability of medical facilities, poor economic conditions, and lack of awareness restricts the growth of the Africa market. Meanwhile, the well-developed economy in the Middle East offers growth opportunities for cochlear implants.

Industry Updates
·         In August 2018, Advanced Bionics, a global leader in cochlear implants, announced FDA approval for its new HiRes Ultra 3D Cochlear Implant. The new cochlear implant is hassle-free and pain-free choice for patients and is equipped with a unique magnet technology.
·         In November 2018, researchers at Asan Medical Center (AMC) developed artificial intelligence (AI)-based prediction platform for cochlear implant surgery. The platform can provide rapid diagnoses, treatment, and rehabilitation of hearing loss.

Comments

Post a Comment

Popular posts from this blog

Proteomics Market Analysis, Demand Overview, Growth Analysis, Current Trends, Updates, and Global Industry Forecast to 2023

Market Highlights: The global proteomics market is anticipated to hold a market value of USD 23.2 billion in the year 2017 and is expected to grow at a CAGR of 14.1% during the forecast period. Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis. Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation prote...
Read more

Pancreatic Cancer Market: America to Command the Largest Share

Market Overview: Pancreatic cancer can be defined as an enlarged tumor, which is generally caused by malignant cells present in the tissues of the pancreas. This type of cancer is generally caused due to drinking alcohol, smoking, genetic factors, radiotherapy in the past, obesity, inflammation of the pancreas, and diabetes mellitus. It is a type of cancer that starts in the pancreas and is a highly lethal disease. The global Pancreatic Cancer Market , as per a report by Market Research Future (MRFR) is touted to register 8.1% CAGR during the forecast period ( 2017-2023 ). The dearth of therapeutic approaches for early-stage detection has resulted in increased incidences of pancreatic cancer. Soaring prevalence of pancreatic cancer has resulted in germline mutations, thereby causing the defective genes to pass down to the children from their parents, thus making early detection of pancreatic cancer important. This has led to the growth of the market across the globe. Surging dem...
Read more

Immune Thrombocytopenia (ITP) Market is Estimated to Record Promising CAGR of 5.78% During Forecast 2018-2023

Market Highlights: As per the latest report published by Market Research Future (MRFR), the Global Immune Thrombocytopenia (ITP) is set to surpass a valuation of USD 2,300 Mn by the year 2023, reflecting a healthy CAGR. ITP is a blood related disorder that cause abnormal clotting. Some of the discomforts caused by the disease include bruising, bleeding and severe drop in platelets counts. Both minors and adults can develop the condition. The disease is classified into primary and secondary form. Primary form of ITP occurs on its own while the latter is an offshoot of another condition. The condition can be triggered by reactive medications, autoimmune disease, pregnancy and certain type of cancers. ITP is among the most commonly occurring disorder across the globe. In addition, the incidence rate has continued to spiral upwards in recent years. Factors as such as are fueling the demand for drugs and therapeutics for ITP. Currently, there are four treatment options available for ...
Read more